Gene Variants Linked to Kidney Disease Risk
Over a thousand gene variants are correlated with membranous nephropathy, an early-stage finding from European kidney datasets.
Updated on Nov. 3, 2026 in Asthma

Researchers applied a multivariate genetic method to European kidney datasets and identified 1,095 HLA and 46 PLA2R1 gene variants correlated with membranous nephropathy, an autoimmune kidney condition. The work, published early as accepted peer-reviewed research, extends earlier single-variant genetic studies of the disease.
Why it matters
Membranous nephropathy is an autoimmune kidney disease whose genetic drivers have been studied one variant at a time, which can miss how variants work together. Looking at combinations of variants may help clinicians and researchers better understand who is at risk and where future treatments might act.
This is a multivariate genetic association analysis applied to the NURTuRE-CKD and Salford Kidney Study European datasets, combined with transcriptomics and single-cell gene enrichment. It identified 1,095 HLA SNPs and 46 PLA2R1 SNPs with significant membranous nephropathy correlation, though sample sizes and effect magnitudes are not reported in the source.
The players
Salford Kidney Study
A kidney research cohort based in Salford, UK, whose European dataset was analyzed in this study.
NURTuRE-CKD
A European chronic kidney disease study whose dataset was analyzed alongside the Salford cohort.
The details
Earlier genome-wide studies examined genetic variants one at a time and identified HLA and PLA2R1 as risk regions for membranous nephropathy. This study instead used canonical correlation analysis to examine how groups of variants relate to the disease together. The team then checked candidate genes against published immune transcriptomics data, finding that ATF6B, C2, CYP21A2 and HLA-DRB1 were differentially expressed in membranous nephropathy, and that HLA-DQB1, HLA-DRB5 and RNF5 varied with lead variant genotype.
Timeline
Article published early as accepted peer-reviewed research on 3 November 2026.
Health Landscape
Earlier genome-wide association studies established HLA and PLA2R1 as the main genetic risk regions for membranous nephropathy, which is an autoimmune kidney condition. This multivariate approach builds on that foundation by testing whether combinations of variants reveal signals that single-variant analyses miss.
This is early research and does not change screening or treatment today. If you have been diagnosed with a kidney condition, the practical takeaway is that genetic research is refining how the disease is understood, so questions about your own care are best raised with your nephrology team.
The takeaway
Genetic research is moving from single variants toward combinations, which may sharpen how autoimmune kidney disease is understood over time. Anyone with concerns about kidney health should discuss them with a physician.
Further reading
Explore more on Asthma, the respiratory condition whose immune and genetic research shares methods with this kidney study.
Source note: This article includes information reported by Nature.


